Latest Breaking News On - Asilea pharmaceutica kurs - Page 1 : comparemela.com

02.10.2023 - Seeking approval for Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP)Prescription Drug User Fee Act (PDUFA) goal date set for April 03, 2024 Ad . Seite 1

Marc engelhardtBasilea pharmaceutica ltdDrug administrationNew drug applicationPrescription drug user fee actChief medical officerQualified infectious disease productAntibiotics incentives nowBasilea pharmaceutica chartAsilea pharmaceutica kursAsilea pharmaceutica aktie